Ignite Creation Date:
2024-05-06 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06192199
Status:
RECRUITING
Last Update Posted:
2024-01-22
First Post:
2023-12-14
Brief Title:
The Diagnostic Value of APTTFibrinogen Ratio in Pulmonary Embolism
Sponsor:
Nanfang Hospital Southern Medical University
Organization:
Nanfang Hospital Southern Medical University
Study Overview
Official Title:
The Diagnostic Value of APTTFibrinogen Ratio in Pulmonary Embolism
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
From January 1 2023 to December 30 2023 patients who were suspected of pulmonary embolism and underwent CTPA examination at Nanyang Hospital of Southern Medical University were divided into pulmonary embolism group and non pulmonary embolism group 1 Collect relevant data including gender age primary disease CTPA imaging and reports BNP troponin electrocardiogram cardiac ultrasound PT APTT TT fibrinogen D-dimer etc and analyze demographic data pulmonary embolism risk grading APTTfibrinogen ratio and determine their cut-off values through statistical analysis of the two groups 2 Follow up on the APTTfibrinogen ratio after anticoagulation treatment and bleeding in the pulmonary embolism group
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None